Argenx, Navan And 3 Stocks To Watch Heading Into Monday - Amrep (NYSE:AXR)

Group 1 - U.S. stock futures are trading higher, indicating potential investor interest in various stocks [1] - MindWalk Holdings Corp. (NASDAQ:HYFT) is expected to report a quarterly loss of $0.01 per share on revenue of $4.00 million, with shares falling 5.4% to close at $1.77 [1] - Argenx SE (NASDAQ:ARGX) has discontinued Phase 3 UplighTED studies of Efgartigimod SC in thyroid eye disease after a futility review, leading to a 1.3% drop in shares to close at $877.94 [1] - Navan Inc. (NASDAQ:NAVN) is anticipated to post a quarterly loss of $0.25 per share on revenue of $182.04 million, with shares gaining 4.53% to $14.55 [1] - AMREP Corp. (NYSE:AXR) reported disappointing second-quarter results, with earnings of $0.22 per share and sales of $9.398 million, both missing analyst estimates, resulting in a 4.1% decline in shares to $20.16 [1] - Champions Oncology Inc. (NASDAQ:CSBR) is expected to report quarterly earnings of $0.01 per share on revenue of $14.04 million, with shares surging 6.3% to close at $6.72 [1]